Clinical Trial Update: Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating external beam radiotherapy with 153Sm-EDTMP for metastatic osteosarcoma; the study is terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• 153Sm-EDTMP (samarium-153-ethylene diamine tetramethylene phosphonate)
• External beam radiotherapy (External beam radiotherapy)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Osteosarcoma | Phase 2 | Status: TERMINATED | Results posted: 2019-10-29